The Boston Red Sox will be without Steven Wright for half of the 2019 season after the MLB levied an 80-game suspension against the pitcher, MLB.com's Mark Feinsand reported on Tuesday afternoon.
Feinsand disclosed that Wright tested positive for a performance-enhancing drug called Growth Hormone Releasing Peptide 2 (GHRP-2), which violates the MLB's Joint Drug Prevention and Treatment Program.
Minutes after reports of Wright's suspension, the Red Sox released a statement (h/t Feinsand):
"The Boston Red Sox fully support Major League Baseball's Joint Drug Prevention and Treatment Program and its efforts to eliminate performance-enhancing substances from the game.